Related Experiment Video
Updated: Apr 27, 2026
06:30
Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
10.5K
Spontaneous rectus sheath hematoma during rivaroxaban therapy
Ibrahim Kocayigit1, Yusuf Can2, Salih Sahinkus2
1Department of Cardiology, Yenikent State Hospital, Turkey.
Indian Journal of Pharmacology
|July 3, 2014
Summary
Rivaroxaban, an anticoagulant, can cause spontaneous rectus sheath hematoma. This rare complication occurred in a patient treated for atrial fibrillation, highlighting a potential risk.
Area of Science:
- Cardiology
- Hematology
- Pharmacology
Background:
- Rivaroxaban is a direct Factor Xa inhibitor used for atrial fibrillation and deep venous thrombosis prophylaxis.
- Anticoagulant therapy necessitates careful monitoring for potential bleeding complications.
Observation:
- A 75-year-old woman developed a spontaneous rectus sheath hematoma.
- The patient was undergoing treatment with rivaroxaban for atrial fibrillation.
Findings:
- The rectus sheath hematoma occurred spontaneously during rivaroxaban therapy.
- This suggests a potential, albeit rare, adverse effect of rivaroxaban.
Implications:
- Clinicians should be aware of the risk of spontaneous rectus sheath hematoma in patients on rivaroxaban.
- Further investigation into the incidence and risk factors for this complication may be warranted.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:17Hemorrhagic Stroke l: Introduction
18
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
18
01:30Venous Thrombosis IV: Nursing Management
413
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
413
01:29Hemorrhagic Stroke ll: Pathophysiology
16
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
16
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K